Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
fexofenadine hydrochloride, Quantity: 120 mg
Dr Reddys Laboratories Australia Pty Ltd
Fexofenadine hydrochloride
Tablet, film coated
Excipient Ingredients: colloidal anhydrous silica; maize starch; magnesium stearate; mannitol; croscarmellose sodium; powdered cellulose; titanium dioxide; hypromellose; allura red AC aluminium lake; iron oxide black; macrogol 400
Oral
10's, 20's and 30's, 50, 60, 70, 80, 90,100
(S2) Pharmacy Medicine
Seasonal allergic rhinitis, in adults and children aged 12 years and over.
Visual Identification: Pink coloured, oval shaped, biconvex tablets, debossed with "FXF" one side and "120" on other side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2011-05-02